Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.

Smit AK, Espinoza D, Newson AJ, Morton RL, Fenton G, Freeman L, Dunlop K, Butow PN, Law MH, Kimlin MG, Keogh LA, Dobbinson SJ, Kirk J, Kanetsky PA, Mann GJ, Cust AE.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):212-221. doi: 10.1158/1055-9965.EPI-16-0395. Epub 2016 Oct 4.

2.

Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?

Smit AK, Keogh LA, Newson AJ, Butow PN, Dunlop K, Morton RL, Kirk J, Espinoza D, Cust AE.

Br J Dermatol. 2017 Sep;177(3):779-790. doi: 10.1111/bjd.15744. Epub 2017 Jul 20.

PMID:
28627002
3.

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.

Glanz K, Volpicelli K, Kanetsky PA, Ming ME, Schuchter LM, Jepson C, Domchek SM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):607-14. doi: 10.1158/1055-9965.EPI-12-1174. Epub 2013 Feb 7.

4.

Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Hay JL, Berwick M, Zielaskowski K, White KA, RodrĂ­guez VM, Robers E, Guest DD, Sussman A, Talamantes Y, Schwartz MR, Greb J, Bigney J, Kaphingst KA, Hunley K, Buller DB.

JMIR Res Protoc. 2017 Apr 25;6(4):e52. doi: 10.2196/resprot.7158.

5.

Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial.

Dieng M, Kasparian NA, Mireskandari S, Butow P, Costa D, Morton R, Mann G, Menzies S, Cust A.

BMJ Open. 2017 Oct 10;7(10):e015195. doi: 10.1136/bmjopen-2016-015195.

6.

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.

Smit AK, Newson AJ, Morton RL, Kimlin M, Keogh L, Law MH, Kirk J, Dobbinson S, Kanetsky PA, Fenton G, Allen M, Butow P, Dunlop K, Trevena L, Lo S, Savard J, Dawkins H, Wordsworth S, Jenkins M, Mann GJ, Cust AE.

Contemp Clin Trials. 2018 Jul;70:106-116. doi: 10.1016/j.cct.2018.05.014. Epub 2018 May 23.

PMID:
29802966
7.

Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation [Internet].

Lin JS, Eder M, Weinmann S, Zuber SP, Beil TL, Plaut D, Lutz K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Feb.

8.

Public preferences for communicating personal genomic risk information: a focus group study.

Smit AK, Keogh LA, Hersch J, Newson AJ, Butow P, Williams G, Cust AE.

Health Expect. 2016 Dec;19(6):1203-1214. doi: 10.1111/hex.12406. Epub 2015 Sep 1.

9.

Sun Exposure and Protection Behaviors among Long-term Melanoma Survivors and Population Controls.

Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, Lazovich D.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):607-613. doi: 10.1158/1055-9965.EPI-16-0854. Epub 2017 Mar 2.

10.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

PMID:
8998184
11.
12.

Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.

Christie D, Thompson R, Sawtell M, Allen E, Cairns J, Smith F, Jamieson E, Hargreaves K, Ingold A, Brooks L, Wiggins M, Oliver S, Jones R, Elbourne D, Santos A, Wong IC, O'Neill S, Strange V, Hindmarsh P, Annan F, Viner R.

Health Technol Assess. 2014 Mar;18(20):1-202. doi: 10.3310/hta18200.

13.

[Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].

Itin PH, Fistarol SK.

Ther Umsch. 2003 Aug;60(8):469-72. German.

PMID:
14502854
14.

A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma.

Wu YP, Nagelhout E, Aspinwall LG, Boucher KM, Parsons BG, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Leachman SA.

Patient Educ Couns. 2018 Mar;101(3):452-459. doi: 10.1016/j.pec.2017.10.008. Epub 2017 Oct 19.

15.

A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.

Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, Heeren T, Sober AJ, Li F, Gilchrest BA.

Cancer. 2006 Aug 15;107(4):806-14.

16.

Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Fenton GL, Smit AK, Freeman L, Badcock C, Dunlop K, Butow PN, Kirk J, Cust AE.

J Genet Couns. 2018 Apr;27(2):370-380. doi: 10.1007/s10897-017-0183-7. Epub 2017 Dec 3.

PMID:
29199389
17.

Targeted melanoma prevention intervention: a cluster randomized controlled trial.

Rat C, Quereux G, Riviere C, Clouet S, Senand R, Volteau C, Dreno B, Nguyen JM.

Ann Fam Med. 2014 Jan-Feb;12(1):21-8. doi: 10.1370/afm.1600.

18.

Genetic counseling in melanoma.

Badenas C, Aguilera P, Puig-Butillé JA, Carrera C, Malvehy J, Puig S.

Dermatol Ther. 2012 Sep-Oct;25(5):397-402. doi: 10.1111/j.1529-8019.2012.01499.x.

19.

Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial.

Glanz K, Volpicelli K, Jepson C, Ming ME, Schuchter LM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):415-21. doi: 10.1158/1055-9965.EPI-14-0926. Epub 2014 Nov 28.

20.

Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial.

Dieng M, Butow PN, Costa DS, Morton RL, Menzies SW, Mireskandari S, Tesson S, Mann GJ, Cust AE, Kasparian NA.

J Clin Oncol. 2016 Dec 20;34(36):4405-4414. Epub 2016 Oct 28.

PMID:
27998215

Supplemental Content

Support Center